Downstream effects of IL-6 in a pro-inflammatory context include increased expression of adhesion molecules, plasminogen activator inhibitor-1, and release of chemokines, which are all known risk factors for hypertension, CVD, and diabetes. This evidence concerns the gene IL6 and hypertensive disorder.